Selective cell ablation in transgenic mice expression E. coli nitroreductase

Gene Ther. 1997 Feb;4(2):101-10. doi: 10.1038/sj.gt.3300367.

Abstract

The gene encoding E. coli nitroreductase (NTR) was expressed in the luminal cells of the mammary gland of transgenic mice using the ovine beta-lactoglobulin promoter. Treatment of NTR expressing animals with the prodrug CB1954 (5-aziridin-1-yl-2-4-dinitrobenzamide) resulted in a rapid and selective killing of this population of cells whereas the closely associated myoepithelial cells were unaffected. NTR-mediated inducible cell ablation offers a number of advantages over the use of HSV1-tk for the selective killing of cells in vivo.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects
  • Aziridines / pharmacology*
  • Cell Culture Techniques
  • Escherichia coli / enzymology
  • Escherichia coli / genetics
  • Female
  • Gene Expression
  • Genetic Therapy / methods*
  • Immunoenzyme Techniques
  • Lactation
  • Lactoglobulins / genetics
  • Mammary Glands, Animal / cytology
  • Mammary Glands, Animal / drug effects
  • Mice
  • Mice, Transgenic
  • Nitroreductases / genetics*
  • Nitroreductases / metabolism
  • Prodrugs / pharmacology*

Substances

  • Antineoplastic Agents
  • Aziridines
  • Lactoglobulins
  • Prodrugs
  • tretazicar
  • Nitroreductases